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Elevation of CAMP has been considered to be an important downregulative signal in the production of interleukin-l(IL-I). This study demonstrates 
that this phenomenon is dependent on the signal used to activate the IL-1 production. The IL-l/I production of lipopolysaczzharide activated human 
monocytes was readily inhibited by dibutyryl CAMP. This took place without a significant change in the steady-state l vels of IL-Q? mRNA. By 
contrast, in PMA activated monocytes 100 FM dibutyryl CAMP increased in IL-la production ca. 4-fold. The steady-statelevels of IL-l/I mRNA 
were also simultaneously increased. 
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1. INTRODUCTION 
Interleukin 1 (IL-l) is a family of related polypep- 
tides, which are efficiently produced by cells of the 
mono~~e/macrophage lineage. Until now two distinct 
forms, IL-la and IL-l@, have been characterized, and 
their genes cloned and sequenced [l]. IL-l exhibits a 
very broad range of biological activities in immune and 
inflammatory reactions as well as in normal 
hematopoiesis (reviewed in [2,3]). It may also be in- 
volved in the malignant growth of myeloid leukemia 
cells 14-61. Because of these activities, it is obvious that 
the precise control of IL-l is of vital importance in 
vivo. IL-l production, at least in vitro, is often 
associated with production of inhibitory proteins, but 
the exact nature and significance of these are still large- 
ly unknown (reviewed in [7]). A better characterized 
negative feedback control mechanism is that exerted by 
prostaglandin-induced elevation of cyclic AMP. This 
has been demonstrated both in bacteriotoxin-activated 
normal macrophages and monocytic leukemia cells 
[&lo]. Increased intracellul~ cyclic AMP levels did 
not alter the steady-state levels of IL-l,8 mRNA [g], 
suggesting that this control operates at the post- 
transcriptional level. It has been previously 
demonstrated that in mono&c cells IL-l,8 gene ex- 
pression can be induced via two distinct, functionahy 
inde~ndent pathways [l l]. The one pathway is ac- 
tivated by protein kinase C activating phorbol esters, 
e.g. PMA, and the other by bacterial lipopolysac- 
charide, LPS. In this report, we show that elevated 
CAMP levels are suppressive only in the LPS-induced 
pathway, while in PMA-stimulated human monocytes 
elevated CAMP levels significantly increase the IL-&& 
mounts produced. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
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Leukocyte-rich buffy coats were obtained from the Finnish Red 
Cross Blood Transfusion Service (Helsinki, Finland) and 
mononuclear cells were isolated from them by centrifugation on 
Ficoll-isopaque (Pharmacia, Uppsala, Sweden). After being washed, 
the cells were resuspended, lo7 cells/ml, in RPMI-1640 medium 
(Flow, Irvine, UK) containing 10% heat-inactivated human AB 
serum (The Finnish Red Cross Blood Transfusion Service), 10 mM 
Hepes, 2 mM L-glutamine, and antibiotics (complete medium). 
10 ml aliquots of this cell suspension were then incubated in 90 mm 
diameter Petri dishes (Costar, Cambridge, MA) at 37’C, 5% COs, 
for 1 h. After incubation the nonadherent cells were removed by 
vigorous pipetting with warm complete medium, and then the 
adherent cells were harvested by incubating the cells in cold PBS 
(Ca” and M2+ free) and using a rubber policeman. 8040% of the 
adherent cells were monocytes, as demonstrated by standard mor- 
phoIogical criteria or with monoclonal, mon~~~s~ific an- 
tibodies. 1 x lo6 adherent cells (in 1 ml of complete medium) were 
cultured (at 37”C, 5% COs) in wells of tissue culture plates @t-well, 
Costar) and the cultures were stimulated with the indicated concen- 
trations of the following agents: phorbol 1Zmyristate 13-acetate 
(PMA, Sigma Chemical Co., St. Louis, MO) or bacterial lipopolysac- 
charide (LPS, E. coli 026:B6, Difco Laboratories, Detroit, MI). 
When indicated, ~-2-~~buty~lad~osine 3 ‘ ,5 ’ -cyclic 
monophosphate (dbcAMP, Sigma), IV-Z-Odibutyrylguanosine 
3 ’ ,5 ‘-cyclic monophosphate (dbcGMP. Sigma), prostaglandin E2 
(PGEZ, Sigma) or forskolin (Sigma) were added to the cultures. After 
24 h, the cultures were harvested after two cycles of freezing and 
thawing. Thus the samples represent the total amount of IL-1 protein 
produced (intracellular, membrane fragments and that released to the 
culture medium). 
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2.2. Assay for IL-I 
The IL-l,5 content of the cultures was measured by using the IL-la 
specific ELISA kit (Cistron, Pine Brook, NJ). The assays were per- 
formed according to the manufacturer’s instructions. 
2.3. RNA isolation and analysis 
For RNA isolations, mononuclear cells from each buffy coat were 
directly divided to the experimental groups indicated (in 90 mm Petri 
dishes), nonadherent cells were removed as described above, and then 
10 ml of complete medium and the indicated stimulators were added. 
To avoid interindividual variations between the buffy coats, each ex- 
perimental group consisted of cells derived from 5-6 buffy coats. At 
the times indicated, the adherent cells were harvested as described 
above and total cellular RNA was isolated by guanidinium isothio- 
cyanate lysis and CsCl centrifugation [12,13]. RNA isolated was 
quantitated spectrophotometrically and 15 pg samples were size- 
fractionated on 0.8% formaldehyde-agarose g ls, transferred to a 
nylon membrane (Pall, Glen Cove, NY), dried and baked at 80°C. 
Table I 
The effect of dibutyryl cyclic AMP (dbcAMP) on the IL-la 
production of human monocytes timulated either with LPS or PMA 
Stimulator IL- 1!5 (P&ml) 
- <20 
LPS 100 ng/ml 33671 
LPS 100 t&ml + dbcAMP IOOpM 11428 
LPS 100 ng/ml + dbcAMP lO/rM 19642 
PMA 10 ng/ml 3359 
PMA 10 ng/ml + dbcAMP lOO/rM 23035 
PMA 10 ng/ml + dbcAMP 1OyM 1173 
dbcAMP 108 /M 136 
dbcAMP 10 CM 45 
1 x lo6 human monocytes (in 1 ml) were cultured with the 
stimulators indicated and after 24 h the cells and supernatants were 
harvested after two cycles of freezing and thawing (thus the samples 
represent he total amount of IL-I,@ protein produced). IL-l.8 was 
measured by IL-l,& specific ELISA 
Table II 
The effect of dibutyryl cyclic GMP (dbcGMP), prostaglandin E2 
(PGE2) and forskolin on the IL-l@ production of human monocytes 
stimulated with LPS or PMA 
Stimulator IL-l,& (pg/ml) 
- 60 
LPS 100 n&ml 36383 
LPS 100 ng/ml + dbcAMP 1OOpM 17358 
LPS 100 nglml + dbcGMP 1OOpM 35937 
LPS 100 ng/ml + PGE2 1 yM 20317 
LPS 100 ng/ml + PGE2 0.1 FM 22 264 
LPS 100 ng/ml + PGE2 0.01 yM 29 575 
LPS 100 ng/mI + forskolin 10/M 30468 
LPS 100 ng/ml + forskolin 1 /cM 36941 
PMA 10 ng/ml 9436 
PMA 10 ng/ml + dbcAMP 1OOpM 26 227 
PMA 10 ng/ml + dbcGMP 100,uM 7816 
PMA 10 ng/ml + PGE2 1 pM 9084 
PMA 10 ng/ml + PGE2 0.1 pM 9014 
PMA 10 n&ml + PGE2 0.01 CM 8802 
PMA 10 ng/ml + forskolin 1OlcM 19150 
PMA 10 ng/ml + forskolin 1 PM 22830 
For explanation see Table I 
36 
The IL-l@ cDNA probe used (HU-IL-la, pcDSRtu) was kindly pro- 
vided by Dr Kari Varkila (DNAX Research Institute, Palo Alto, CA). 
The RNA levels in the nylon membranes were also quantitated (data 
not shown) by using a constant probe, glyceraldehyde phosphate 
dehydrogenase (pRGAPDH-13). This was obtained from Dr Kari 
Alitalo (Dept. Pathology, University of Helsinki). The cDNA probes 
were labeled with 32P by nick-translation. Prehybridizations and 
hybridizations were performed in a solution containing 50% for- 
mamide, 1 x Denhardt’s solution, 3 x SSC, 50 mM Hepes and 
150pg/mt of salmon sperm DNA. Filters were washed in 1 x SSC 
plus 0.1% SDS, 2 times for 30 min at room temperature and then at 
60°C for 30 min. Then the filters were exposed to Kodak AR X-Omat 
films at -70°C with intensifying screens. 
3. RESULTS 
Monocyte cultures contained 3-10 times more IL-lfl 
protein after the optimal LPS stimulation (100 ng/ml) 
than after the optimal PMA stimulation (10 ng/ml). 
The cell permeable structural analog of cyclic AMP, 
dbcAMP, had a clear dose-dependent suppressive f- 
fect on the LPS-induced IL-l@ production (Table I), 
thus being in accordance with the previous results [8,9]. 
By contrast, dbcAMP clearly enhanced the PMA in- 
duced IL-Q3 production (Table I). In monocytes deriv- 
ed from different cell donors, the increasing effect of 
100 pM dbcAMP varied between 1.96 and 6.86 fold 
,” \ 3h 
16 h 
Fig. 1. The effect of dbcAMP on the IL-l,& mRNA expression 
induced either by LPS or PMA. Monocytes were cultured for 3 h or 
16 h in the presence of the agents indicated, and then total cellular 
RNA was isolated, fractionated on agarose gels, transferred to a 
nylon membrane and then hyb~dized to 3zP-labelled IL-l@ cDNA 
probe. 
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(mean 4.13, n = 5), 100 FM dbcAMP alone only slight- 
ly increased the IL-l,& production (maximally up to 
400 pg/ml). The butyrate moiety of the dbcAMP 
molecule was not responsible for the enhancing effect, 
because dbcGMP was entirely inactive (Table II). The 
agonist (PGE2 or forskolin)-induced CAMP elevation 
clearly suppressed the LPS-induced IL-l,& production, 
PGE2 being more effective, while in PMA stimulated 
cultures forskolin enhanced the IL-l@ production, but 
PGE2 was without any effect (Table II). 
It has been reported that elevated intracellular CAMP 
levels do not have any influence on the IL-b3 mRNA 
levels in LPS activated macrophages or in bacteriotoxin 
activated U937 cells [8,14]. The same was true also in 
LPS-activated human monocytes (Fig. 1). By contrast, 
the enhancing effect of dbcAMP in the PMA induced 
IL-l,@ production could be seen at the transcriptional 
level: IL-l@ mRNA levels were clearly higher in the cells 
stimulated for 16 h with PMA plus 100 PM dbcAMP 
than in cells stimulated with PMA alone (Fig. 1). 
Earlier after the stimulation (3 h), the enh~cing effect 
was not yet visible (Fig. 1). 
4. DISCUSSION 
The data shown in this report demonstrate that eleva- 
tion of intracellular CAMP can either down- or 
upregulate the IL-l,& production of human monocytes 
and, additionally, that these opposite regulatory effects 
are mediated via different mechanisms. 
Downregulation of the IL-l,& production was observ- 
ed after LPS stimulation. Elevated CAMP levels did not 
change the steady-state levels of IL-l@ mRNA in this 
case. In PMA-stimulated cells CAMP had a clear 
enhancing effect on the mRNA levels, and consequent- 
ly, on the IL-lfl protein production. Fenton et al. [ 111 
have shown that PMA induces a stable (Ti/2 = 12 h) 
IL-l@ mRNA, while after LPS stimulation the 
predominant mRNA is short-lived (7’112 = 4 h). Thus, 
it is possible that the CAMP mediated upregulatory 
mechanisms are working only on this more stable 
mRNA form. We are currently analyzing the effects of 
CAMP on the rate of transcription and stability of the 
IL- 1P mRNA. 
The differences between the LPS- and PMA-induced 
activation pathways are still poorly characterized. It is 
evident that protein kinase C is also involved in the 
LPS-induced pathway, because inhibitors of this kinase 
are able to block the IL-b9 mRNA accumulation and 
protein production in LPS activated macrophages f 151. 
PMA-induced IL-b3 production was also enhanced 
by a receptor agonist, forskolin, which is able to elevate 
the endogenous CAMP levels. However, another 
agonist, PGE2, was ineffective, although it was clearly 
decreasing the LPS-induced IL-la production. The 
reason for this is unknown, but it is possible that PMA 
treatment selectively downregulates the agonist- 
induced CAMP responses. This kind of phenomenon 
has been observed for example in B lymphocytes [ 161. 
The two signal tr~sduction systems, one activated 
by e.g. phorbol esters and involving protein kinase C, 
and the other activated by CAMP and involving protein 
kinase A, can interact in various ways [17]. The effect 
of CAMP on the PMA induced IL-l/3 production 
described here is an example of the synergistic interac- 
tions, which are operating at the levels of gene 
transcription. It is interesting to note that the produc- 
tion of another cytokine, interleukin-6, which is also 
mainly produced by cells of the monocyte/macrophage 
lineage, can also be activated by protein kinase C or 
CAMP dependent pathways [18]. In that case, however, 
these pathways do not interact with each other [18]. 
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